277 related articles for article (PubMed ID: 26814431)
1. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Al-Jameel W; Gou X; Forootan SS; Al Fayi MS; Rudland PS; Forootan FS; Zhang J; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2017 May; 8(19):31041-31056. PubMed ID: 28415688
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target.
Naeem AA; Abdulsamad SA; Rudland PS; Malki MI; Ke Y
Precis Clin Med; 2019 Oct; 2(3):192-196. PubMed ID: 35694437
[TBL] [Abstract][Full Text] [Related]
4. FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
Naeem AA; Abdulsamad SA; Zeng H; He G; Jin X; Zhang J; Alenezi BT; Ma H; Rudland PS; Ke Y
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38131188
[TBL] [Abstract][Full Text] [Related]
5. Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ.
Al-Jameel W; Gou X; Jin X; Zhang J; Wei Q; Ai J; Li H; Al-Bayati A; Platt-Higgins A; Pettitt A; Rudland PS; Ke Y
Genes Cancer; 2019 May; 10(3-4):80-96. PubMed ID: 31258834
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms on how FABP5 inhibitors promote apoptosis-induction sensitivity of prostate cancer cells.
Zhang J; He G; Jin X; Alenezi BT; Naeem AA; Abdulsamad SA; Ke Y
Cell Biol Int; 2023 May; 47(5):929-942. PubMed ID: 36651331
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
9. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
[TBL] [Abstract][Full Text] [Related]
10. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
Forootan SS; Bao ZZ; Forootan FS; Kamalian L; Zhang Y; Bee A; Foster CS; Ke Y
Int J Oncol; 2010 Jan; 36(1):69-76. PubMed ID: 19956834
[TBL] [Abstract][Full Text] [Related]
11. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
12. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
[TBL] [Abstract][Full Text] [Related]
13. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
[TBL] [Abstract][Full Text] [Related]
14. PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis.
Peeters LL; Vigne JL; Tee MK; Zhao D; Waite LL; Taylor RN
Angiogenesis; 2005; 8(4):373-9. PubMed ID: 16400517
[TBL] [Abstract][Full Text] [Related]
15. Activation of β2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARγ.
Zhou J; Liu Z; Zhang L; Hu X; Wang Z; Ni H; Wang Y; Qin J
Cancer Res Treat; 2020 Jul; 52(3):830-847. PubMed ID: 32138468
[TBL] [Abstract][Full Text] [Related]
16. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial Cells.
Cazzaniga A; Locatelli L; Castiglioni S; Maier J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933613
[TBL] [Abstract][Full Text] [Related]
19. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
